DJIA 15,973.84 313.66 2.00%
NASDAQ 4,337.51 70.68 1.66%
S&P 500 1,864.78 35.70 1.95%
market minute promo


company name or ticker

Ligand Pharmaceuticals (LGND): Q4 Earnings Preview

Spectrum (SPPI) Initiates Phase III Study on SPI-2012

Weak On High Volume: Spectrum Pharmaceuticals (SPPI)

Arbutus Biopharma Is Currently In Second Place In The Race For An HBV Cure

8-K Filings Shows Spectrum Pharma Signs Partnersship With Servier Canada, Will Receive $6M Upfront

Spectrum Pharmaceuticals and Onxeo Announce Complete Response in 67% of Patients with Peripheral T-C

Spectrum Pharmaceuticals and Onxeo Announce Complete Response in 67% of Patients with Peripheral T-Cell Lymphoma in Combination of Belinostat and Standard CHOP

US Stock Futures Signal Higher Start On Wall Street

Spectrum Pharmaceuticals Submits Phase 2 Breast Cancer Protocol to FDA as Part of an Investigational

Spectrum Pharmaceuticals Submits Phase 2 Breast Cancer Protocol to FDA as Part of an Investigational New Drug (IND) Application for Poziotinib

Spectrum (SPPI) Up on Selling Zevalin Rights to Mundipharma

Health Care Sector Update for 11/18/2015: PFE, SPPI, AVXL

See More Articles...